OpenVSafe by OpenVAERS
Search V-safe

BMR-13526-87829

1 vaccination 2 coded responses 2 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
816 / CO
Registered
2021-04-09
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-09
    Registered in v-safe
  2. 2021-04-09
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-04-09
    Survey response — day 0, dose 1
    MedDRA: Syncope — Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness
    Free text: Fainted
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Syncope — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Free text: Fainting
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-10
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    no matching call case

Vaccinations

DoseDateManufacturerCo-administered
12021-04-09Janssen/Johnson & Johnson

Call center

1 check-in flagged for a call with no call center case on record

See the call center timeline

Free text

Release 7 — day 0, dose 1

2021-04-09

Systemic reaction (other): Fainted

Release 7 — days 1–6 daily, dose 1

2021-04-10

Systemic reaction (other): Fainting

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROSyncope ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release